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Fighting Alzheimer’s by defusing a death receptor
A 
receptor that incites cell suicide also promotes the 
accumulation of β-amyloid plaques in Alzheimer’s 
disease (AD), as He et al. show on page 829. In mice 
prone to the brain buildups, eliminating the receptor cut the 
number of plaques and spared memory. The results point to new 
treatments for the incurable disease.
As plaques of β-amyloid collect in the brains of AD patients, 
large numbers of neurons die. Scientists suspect that this devas-
tation stems from abnormal processing of APP, which leads to 
too much β-amyloid, or out-of-control infl  ammation—or  a 
combination of the two.
A potential link between these two mechanisms is the tumor 
necrosis factor type 1 death receptor (TNFR1), which triggers 
brain cells to kill themselves. TNF-α, which is activated during 
brain infl  ammation, switches on the receptor. Three years ago, 
the researchers showed that β-amyloid could also stimulate 
TNFR1. He et al. wanted to determine whether TNFR1 affects 
plaque accumulation and APP processing.
Their subjects were mice that lack TNFR1 and pump out 
excess APP. Without the receptor, more neurons survived, and 
the animals carried fewer, smaller plaques. Their brains sport-
ed smaller numbers of activated microglia, infl  ammation-pro-
moting immune cells that are 
switched on in AD. The rodents 
also performed better on two 
memory tests.
Removal of TNFR1 also 
slashed the amount of β-amyloid 
the mice fashioned by cutting the 
amount and activity of β-secre-
tase, one of the enzymes that 
snips APP to make β-amyloid. 
TNF-α normally spurs β-secre-
tase production through a path-
way that requires NF-κB, the 
researchers found.
Overall, the study indicates 
that TNFR1 is pivotal in a de-
structive positive feedback loop. 
Infl  ammation boosts the amount 
of TNF-α, cranking up the death receptor pathway and produc-
ing more β-amyloid, which in turn further stimulates TNFR1. 
Drugs that block TNFR1 might short-circuit this pathway and 
save the brain cells of AD patients. 
The long and short 
of mitochondrial fusion
M
itochondria malfunction unless they occasionally fuse with each other. Papers 
by Song et al. (page 749) and Griparic et al. (page 757) now elucidate 
the protein processing necessary for these mergers and pin down one of the 
responsible enzymes.
A protein matchmaker that promotes mitochondrial unions is OPA1, which is located in 
the organelle’s inner membrane. The protein is faulty in dominant optic atrophy, an inherited 
form of blindness. OPA1’s many varieties—there are eight mRNA splice variants, each of 
which encodes polypeptides that undergo further processing—fall into two categories: long 
and short. Yeast harbor a similar protein and require both lengths for fusion. But a previous 
study suggested that only the long form is responsible for mitochondrial fusion in mammals.
Song et al. wanted to determine what the short forms were doing. They engineered 
mouse ﬁ  broblasts that lacked the gene for OPA1 to manufacture different combinations of 
long and short variants. Long versions alone didn’t spur mitochondria to get together, the 
researchers found. Nor did the short forms. But mitochondria coalesced in cells that 
produced a mixture of long and short OPA1. The researchers suspect that their results differ 
from the previous ﬁ  nding because that group used RNAi to knock down OPA1, and some 
residual short proteins might have persisted in the cells.
Several proteins might cut OPA1 down to size. Song et al. found that the enzyme Yme1L 
triggers cuts at one position in OPA1, suggesting that it directly or indirectly helps produce the 
short form. Work by Griparic et al. also implicated the enzyme in slicing OPA1 to promote 
fusion. Their results also suggest that another unidentiﬁ  ed protein is involved. The next 
question for researchers to tackle is why fusion requires both types of OPA1. 
𝗃-amyloid (green) clumps in the 
blood vessels of control mice 
(above), but the vessels of rodents 
lacking TNFR1 are clear (below).
In a cell lacking OPA1 (top), mitochondria 
(red and green) remain aloof, but the 
combination of long and short OPA1 
isoforms spurs them to fuse (bottom).